| CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients CJ Turtle, LA Hanafi, C Berger, TA Gooley, S Cherian, M Hudecek, ... The Journal of clinical investigation 126 (6), 2123-2138, 2016 | 2094 | 2016 |
| The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms JD Khoury, E Solary, O Abla, Y Akkari, R Alaggio, JF Apperley, R Bejar, ... leukemia 36 (7), 1703-1719, 2022 | 1762 | 2022 |
| Endothelial activation and blood–brain barrier disruption in neurotoxicity after adoptive immunotherapy with CD19 CAR-T cells J Gust, KA Hay, LA Hanafi, D Li, D Myerson, LF Gonzalez-Cuyar, C Yeung, ... Cancer discovery 7 (12), 1404-1419, 2017 | 1172 | 2017 |
| Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure J Gauthier, AV Hirayama, J Purushe, KA Hay, J Lymp, DH Li, CCS Yeung, ... Blood, The Journal of the American Society of Hematology 135 (19), 1650-1660, 2020 | 283 | 2020 |
| T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant AG Chapuis, DN Egan, M Bar, TM Schmitt, MS McAfee, KG Paulson, ... Nature medicine 25 (7), 1064-1072, 2019 | 275 | 2019 |
| Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide CG Kanakry, DG Coffey, AMH Towlerton, A Vulic, BE Storer, J Chou, ... JCI insight 1 (5), 2016 | 131 | 2016 |
| Estrogen, progesterone, and HER2/neu receptor discordance between primary and metastatic breast tumours—a review C Yeung, J Hilton, M Clemons, S Mazzarello, B Hutton, F Haggar, ... Cancer and Metastasis Reviews 35, 427-437, 2016 | 105 | 2016 |
| Clinical significance of human coronavirus in bronchoalveolar lavage samples from hematopoietic cell transplant recipients and patients with hematologic malignancies C Ogimi, AA Waghmare, JM Kuypers, H Xie, CC Yeung, WM Leisenring, ... Clinical Infectious Diseases 64 (11), 1532-1539, 2017 | 82 | 2017 |
| Epigenetically aberrant stroma in MDS propagates disease via Wnt/β-catenin activation TD Bhagat, S Chen, M Bartenstein, AT Barlowe, D Von Ahrens, ... Cancer research 77 (18), 4846-4857, 2017 | 70 | 2017 |
| Hematopoietic cell transplantation for myelofibrosis: the dynamic international prognostic scoring system plus risk predicts post-transplant outcomes BTS Bannow, RB Salit, BE Storer, EA Stevens, D Wu, C Yeung, M Fang, ... Biology of Blood and Marrow Transplantation 24 (2), 386-392, 2018 | 66 | 2018 |
| Molecular mechanisms of resistance to tyrosine kinase inhibitors M Yaghmaie, CCS Yeung Current Hematologic Malignancy Reports 14, 395-404, 2019 | 46 | 2019 |
| Comprehensive validation of a real-time quantitative bcr-abl assay for clinical laboratory use CD Jones, C Yeung, JL Zehnder American journal of clinical pathology 120 (1), 42-48, 2003 | 42 | 2003 |
| Factors determining responses to azacitidine in patients with myelodysplastic syndromes and acute myeloid leukemia with early post-transplantation relapse: a prospective trial J Woo, HJ Deeg, B Storer, C Yeung, M Fang, M Mielcarek, BL Scott Biology of Blood and Marrow Transplantation 23 (1), 176-179, 2017 | 39 | 2017 |
| The KDM2B-let-7b-EZH2 axis in myelodysplastic syndromes as a target for combined epigenetic therapy E Karoopongse, C Yeung, J Byon, A Ramakrishnan, ZJ Holman, ... PLoS One 9 (9), e107817, 2014 | 35 | 2014 |
| Rituximab is associated with improved survival in Burkitt lymphoma: a retrospective analysis from two US academic medical centers TM Wildes, L Farrington, C Yeung, AM Harrington, KV Foyil, J Liu, ... Therapeutic Advances in Hematology 5 (1), 3-12, 2014 | 34 | 2014 |
| An update on molecular biology of cutaneous T cell lymphoma R Walia, CCS Yeung Frontiers in oncology 9, 1558, 2020 | 33 | 2020 |
| Human herpesvirus 6B and lower respiratory tract disease after hematopoietic cell transplantation JA Hill, LK Vande Vusse, H Xie, EL Chung, CCS Yeung, S Seo, ... Journal of Clinical Oncology 37 (29), 2670-2681, 2019 | 29 | 2019 |
| Secondary cytogenetic abnormalities in core-binding factor AML harboring inv (16) vs t (8; 21) SY Han, K Mrózek, J Voutsinas, Q Wu, EA Morgan, H Vestergaard, ... Blood advances 5 (10), 2481-2489, 2021 | 28 | 2021 |
| Comparison of four next generation sequencing platforms for fusion detection: Oncomine by ThermoFisher, AmpliSeq by illumina, FusionPlex by ArcherDX, and QIAseq by QIAGEN X Qu, C Yeung, I Coleman, PS Nelson, M Fang Cancer genetics 243, 11-18, 2020 | 28 | 2020 |
| Impact of clinical, cytogenetic, and molecular profiles on long-term survival after transplantation in patients with chronic myelomonocytic leukemia J Woo, DR Choi, BE Storer, C Yeung, AB Halpern, RB Salit, ML Sorror, ... Haematologica 105 (3), 652, 2020 | 28 | 2020 |
